Yada Koji 矢田弘史

… Alternative Names

YADA Koji 矢田弘史

Less

Researcher Number	30635785
Other IDs
Affiliation (Current)	2025: 奈良県立医科大学, 医学部附属病院, 研究員
Affiliation (based on the past Project Information) *help	2023 – 2024: 奈良県立医科大学, 医学部附属病院, 研究員 2022: 独立行政法人国立病院機構大阪医療センター(臨床研究センター), その他部局等, 科長・グループリーダークラス 2021: 独立行政法人国立病院機構大阪医療センター(臨床研究センター), その他部局等, 研究員 2017 – 2020: 奈良県立医科大学, 医学部, 助教 2014 – 2017: 奈良県立医科大学, 医学部, 特任助教 2013 – 2014: 奈良県立医科大学, 医学部, その他
Review Section/Research Field	Principal Investigator Basic Section 52050:Embryonic medicine and pediatrics-related / Pediatrics Except Principal Investigator Pediatrics
Keywords	Principal Investigator 血友病A / インヒビター / 血友病 / 第VIII因子 / F8遺伝子変異 / 凝固異常 / 遺伝子 / 保因者 / 凝固機能 / 分子異常症 … More / 第X因子 / 活性化第VII因子 / 活性化・不活性化 / FVIII / 出血性疾患 / 新規治療 / 血液凝固 … More Except Principal Investigator 血栓止血 / 血液 / 小児科 / 内科 / リン脂質 / 活性型第X因子 / 活性型第IX因子 / トロンビン / 遺伝子治療 / 高機能型 / 第X因子 / 第IX因子 / 第VIII因子 / 血友病A / 血友病 Less

生体内病的環境下における血友病Aの病態解析と凝血学特性に基づく新規治療戦略の開発Principal Investigator
- Principal Investigator
  
  矢田弘史
- Project Period (FY)
  2024 – 2026
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Review Section
  
  Basic Section 52050:Embryonic medicine and pediatrics-related
- Research Institution
  Nara Medical University
血友病A患者・保因者の第Ⅷ因子遺伝子型に基づく病態解析と新規個別化治療戦略の開発Principal Investigator
- Principal Investigator
  
  矢田弘史
- Project Period (FY)
  2021 – 2024
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Review Section
  
  Basic Section 52050:Embryonic medicine and pediatrics-related
- Research Institution
  Nara Medical University
  National Hospital Organization Osaka National Hospital Institute for Clinical Reserch
Development of novel therapeutic strategy based on hemostatic characteristics of FVIII in the patients with moderate/mild hemophilia APrincipal Investigator
- Principal Investigator
  
  Yada Koji
- Project Period (FY)
  2018 – 2020
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Review Section
  
  Basic Section 52050:Embryonic medicine and pediatrics-related
- Research Institution
  Nara Medical University
Studies on molecular pathology of hemophilia A and gain-of-function of FVIII
- Principal Investigator
  
  Midori Shima
- Project Period (FY)
  2017 – 2019
- Research Category
  
  Grant-in-Aid for Scientific Research (B)
- Research Field
  
  Pediatrics
- Research Institution
  Nara Medical University
Basic research on establishment of a novel hemostatic treatment based on the hemostatic potential for mild hemophilia A with inhibitorPrincipal Investigator
- Principal Investigator
  
  Yada Koji
- Project Period (FY)
  2015 – 2017
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Research Field
  
  Pediatrics
- Research Institution
  Nara Medical University
Basic reserch on hemostasis to establish a novel hemostatic therapy for hemophilia A patients with inhibitorsPrincipal Investigator
- Principal Investigator
  
  YADA Koji
- Project Period (FY)
  2013 – 2014
- Research Category
  
  Grant-in-Aid for Young Scientists (B)
- Research Field
  
  Pediatrics
- Research Institution
  Nara Medical University

All 2023 2022 2020 2019 2018 2017 2016 2015 2014 2013

All Journal Article Presentation

[Journal Article] Comparisons of global coagulation potential and bleeding episodes in emicizumab-treated hemophilia A patients and mild hemophilia A patients2022
- Author(s)
  Yuto Nakajima, Kuniyoshi Mizumachi, Naruto Shimonishi, Shoko Furukawa, Koji Yada, Kenichi Ogiwara, Masahiro Takeyama, Midori Shima, Keiji Nogami
- Journal Title
  
  International Journal of Hematology
  
  Volume: 115 Issue: 4 Pages: 489-498
- DOI
  10.1007/s12185-021-03276-7
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-21K07856
[Journal Article] Emicizumab improves ex vivo clotting function in patients with mild/moderate hemophilia A2020
- Author(s)
  Nakajima Yuto、Nogami Keiji、Yada Koji、Furukawa Shoko、Noguchi-Sasaki Mariko、Hirata Michinori、Shima Midori
- Journal Title
  
  Thrombosis and Haemostasis
  
  Volume: オンライン Issue: 06 Pages: 968-976
- DOI
  10.1055/s-0040-1710315
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-17H04231, KAKENHI-PROJECT-18K07798
[Journal Article] Assessment of self‐/parent‐reported quality of life in Japanese children with haemophilia using the Japanese version of KIDSCREEN‐522020
- Author(s)
  Furuichi Yasuko、Nogami Keiji、Yada Koji、Nezu Satoko、Obayashi Kenji、Saeki Keigo、Kurumatani Norio、Nakajima Mitsuru、Kinoshita Seiji、Shima Midori
- Journal Title
  
  Haemophilia
  
  Volume: 26 Issue: 2 Pages: 243-250
- DOI
  10.1111/hae.13945
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-17H04231
[Journal Article] Novel Insights and New Developments Regarding Coagulation Revealed by Studies of the Anti-Factor IXa (Activated Factor IX)/Factor X Bispecific Antibody, Emicizumab.2020
- Author(s)
  Yada K, Nogami K
- Journal Title
  
  Arteriosclerosis, Thrombosis, and Vascular Biology.
  
  Volume: 40(5) Issue: 5 Pages: 1148-1154
- DOI
  10.1161/atvbaha.120.312919
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-18K07798
[Journal Article] Global coagulation function assessed by rotational thromboelastometrypredicts coagulation-steady state in individual hemophilia A patients receiving emicizumab prophylaxis.2019
- Author(s)
  Yada K , Nogami K, Ogiwara K, Shida Y, Furukawa S, Yaoi H, Takeyama M, Kasai R,Shima M.
- Journal Title
  
  International Journal of Haematology
  
  Volume: 110(4) Issue: 4 Pages: 419-430
- DOI
  10.1007/s12185-019-02698-8
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-18K07798, KAKENHI-PROJECT-17K10125, KAKENHI-PROJECT-17K10126
[Journal Article] Whole blood ristocetin-induced platelet impedance aggregometry does not reflect clinical severity in patients with type 1 von Willebrand disease. Haemophilia.2019
- Author(s)
  Nakajima Y, Nogami K, Yada K , Ogiwara K, Furukawa S, Shimonishi N, Shima M.
- Journal Title
  
  Haemophilia
  
  Volume: 25(3) Issue: 3
- DOI
  10.1111/hae.13725
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-18K07798
[Journal Article] Spotlight on emicizumab in the management of hemophilia A:patient selection and special considerations.2019
- Author(s)
  Yada K , Nogami K
- Journal Title
  
  Journal of blood medicine
  
  Volume: 10 Pages: 171-181
- DOI
  10.2147/jbm.s175952
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-18K07798
[Journal Article] Factor (F)VIII/VIIa enhances global haemostatic function in the co-presence of bypassing agents and FVIII among patients with haemophilia A with inhibitor2018
- Author(s)
  Nogami K, Matsumoto T, Yada K, Ogiwara K, Furukawa S, Shida Y, Takeyama M, Shima M
- Journal Title
  
  Br J Haematol
  
  Volume: ahead of printing Issue: 4 Pages: 528-536
- DOI
  10.1111/bjh.15209
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-17K10126, KAKENHI-PROJECT-17H04231, KAKENHI-PROJECT-15K09663, KAKENHI-PROJECT-15K09664, KAKENHI-PROJECT-17K10127, KAKENHI-PROJECT-18K07798, KAKENHI-PROJECT-18K07885
[Journal Article] Emicizumab-mediated haemostatic function in patients with haemophilia A is down-regulated by activated protein C through inactivation of activated factor V2018
- Author(s)
  Yada Koji、Nogami Keiji、Shinozawa Keiko、Kitazawa Takehisa、Hattori Kunihiro、Amano Kagehiro、Fukutake Katsuyuki、Shima Midori
- Journal Title
  
  British Journal of Haematology
  
  Volume: 183 Issue: 2 Pages: 257-266
- DOI
  10.1111/bjh.15525
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-17H04231
[Journal Article] Successful prophylaxis using activated prothrombin complex concentrates (aPCC) in a severe haemophilia A patient with inhibitor previously unresponsive to on-demand daily infusions of aPCC.2017
- Author(s)
  Furukawa S, Nogami K, Ogiwara K, Yada K, Shima M.
- Journal Title
  
  Haemophilia.
  
  Volume: 23 Issue: 5
- DOI
  10.1111/hae.13310
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-15K09663, KAKENHI-PROJECT-15K09664
[Journal Article] Assessing the clinical severity of type 1 von Willebrand disease patients with a microchip flow-chamber system.2016
- Author(s)
  Nogami K, Ogiwara K, Yada K, Shida Y, Takeyama M, Yaoi H, MinamiH, Furukawa S, Hosokawa K, Shima M
- Journal Title
  
  Journal of Thrombosis and Haemostasis
  
  Volume: 14(4) Pages: 667-674
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-15K09664
[Journal Article] Mild hemophilia A patient with novel Pro1809Leu mutation develops an anti-C2 antibody inhibiting allogenic but not autologous factor VIII activity.2015
- Author(s)
  Yada K, Nogami K, Takeyama M, Ogiwara K, Wakabayashi H, Shima M
- Journal Title
  
  J Thromb Haemost
  
  Volume: 13 Issue: 10 Pages: 1843-1853
- DOI
  10.1111/jth.13118
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-15K09664, KAKENHI-PROJECT-26461592, KAKENHI-PROJECT-25293237
[Journal Article] Systematic monitoring of hemostatic management in hemophilia A patients with inhibitor in the perioperative period using rotational thromboelastometry.2015
- Author(s)
  Furukawa S, Nogami K, Ogiwara K, Yada K, Minami H, Shima M.
- Journal Title
  
  J Thromb Haemost
  
  Volume: 13 Issue: 7 Pages: 1279-1284
- DOI
  10.1111/jth.12987
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-15K09664
[Journal Article] 血友病の治療の進歩2015
- Author(s)
  矢田弘史, 嶋　緑倫
- Journal Title
  
  小児科診療
  
  Volume: 78 Pages: 1780-1788
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-15K09664
[Journal Article] 血栓止血性疾患の遺伝子診断―出血性疾患2015
- Author(s)
  矢田弘史, 野上恵嗣
- Journal Title
  
  日本血栓止血学会誌
  
  Volume: 26 Pages: 513-517
- NAID
  130005102998
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-15K09664
[Journal Article] The first case of int1h-related inversion in Japanese haemophilia A patients.2014
- Author(s)
  Yada K, Nogami K, Kawamura T, Minami H, Shima M
- Journal Title
  
  Haemophilia
  
  Volume: 20(6) Issue: 6
- DOI
  10.1111/hae.12509
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-25860878, KAKENHI-PROJECT-26461593
[Journal Article] 血友病に対する治療の進歩(1)-長時間作用型薬剤・抗体医薬の面から-2014
- Author(s)
  矢田弘史，野上恵嗣
- Journal Title
  
  臨床血液
  
  Volume: 55 Pages: 893-898
- NAID
  130004688002
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-25860878
[Journal Article] Activated prothrombin complex concentrate (APCC)-mediated activation of factor (F)VIII in mixtures of FVIII and APCC enhances hemostatic effectiveness.2013
- Author(s)
  Yada K, Nogami K, Ogiwara K, Shima M
- Journal Title
  
  Journal of Thrombosis and Haemostasis
  
  Volume: 11(5) Issue: 5 Pages: 902-910
- DOI
  10.1111/jth.12197
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-24591558, KAKENHI-PROJECT-25860878
[Journal Article] The mild phenotype in severe hemophilia A with Arg1781His mutation is associated with enhanced binding affinity of factor VIII for factor X.2013
- Author(s)
  Yada K, Nogami K, Wakabayashi H, Fay PJ, Shima M.
- Journal Title
  
  Thrombosis and Haemostasis
  
  Volume: 109(6) Issue: 06 Pages: 1007-1015
- DOI
  10.1160/th12-10-0762
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-24591558, KAKENHI-PROJECT-25860878
[Journal Article] Different factor VIII neutralizing effects on anti-factor VIII inhibitor antibodies associated with epitope specificity and von Willebrand factor.2013
- Author(s)
  Yada K, Nogami K, Shima M.
- Journal Title
  
  British Journal of Haematology
  
  Volume: 163(1) Issue: 1 Pages: 104-111
- DOI
  10.1111/bjh.12473
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-24591558, KAKENHI-PROJECT-25860878
[Presentation] 包括的凝固機能に基づく血友病保因者における凝固線溶能の評価2023
- Author(s)
  矢田弘史,　西田恭治
- Organizer
  第45回日本血栓止血学会学術集会
- Data Source
  KAKENHI-PROJECT-21K07856
[Presentation] Additive effect on the global clotting function in moderate/mild hemophilia A by addition of emicizumab, evaluated by clot waveform analysis2019
- Author(s)
  Nakajima Y, Nogami K, Yada K, Furukawa S, Noguchi M, Hirata M, Shima M
- Organizer
  International Society on Thrombosis and Hemostasis
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-17H04231
[Presentation] インヒビター保有血友病A患者における活性型第VII因子による凝固改善に必要な第X因子に関する定量的検討2019
- Author(s)
  矢田弘史、野上恵嗣、坪田夏芽、嶋　緑倫
- Organizer
  第81回日本血液学会学術集会
- Data Source
  KAKENHI-PROJECT-18K07798
[Presentation] A Novel Mechanism of Factor VIIa/Tissue Factor (TF)-Catalyzed Activation and Inactivation of B-Domain-Deleted Factor VIII in the Early Initiation Phases of Coagulation2018
- Author(s)
  Yuto Nakajima, Koji Yada, Keiji Nogami, Midori Shima
- Organizer
  ６０thAmerican Society of Hematology　Annual Meeting and Exposition
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-17H04231
[Presentation] 1.Bドメイン除去(BDD)第VIII 因子(FVIII)においてFVIIa/TF 惹起FVIII 不活化は遷延される2018
- Author(s)
  中島　由翔，矢田弘史，野上恵嗣，嶋緑倫
- Organizer
  第40回日本血栓止血学会学術集会
- Data Source
  KAKENHI-PROJECT-18K07798
[Presentation] Utility of converted factor VIII activity by thrombin generation assay for evaluation of clotting function among hemophilia A carriers2018
- Author(s)
  Nogami K, Kawamura T, Shima M, Yada K
- Organizer
  World Federation of Hemophilia 2018
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-17H04231
[Presentation] 4.A Novel Mechanism of Factor VIIa/Tissue Factor (TF)-Catalyzed Activation and Inactivation of B-Domain-Deleted Factor VIII in the Early Initiation Phases of Coagulation2018
- Author(s)
  Yuto Nakajima, Koji Yada, Keiji Nogami, Midori Shima
- Organizer
  60th American Society of Hematology
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-18K07798
[Presentation] Tenase(Xase) 反応軸に基づく中等症・軽症血友病Aにおける異常FVIIIの多元的機能解析2017
- Author(s)
  矢田　弘史, 野上　恵嗣, 竹中亜利沙, 河村　武志, 嶋　　緑倫
- Organizer
  第39回　日本血栓止血学会
- Data Source
  KAKENHI-PROJECT-17H04231
[Presentation] Mode of enhancement in the global hemostatic potentials with concomitant use of bypassing agents and emicizumab in hemophilia A patients with inhibitor evaluated by ROTEM.2017
- Author(s)
  Yada K, Nogami K, Kitazawa T, Hattori K, Shima M
- Organizer
  The XXVI Congress of the ISTH and 63rd Annual Scientific and Standardization Committee (SSC) Meeting
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-15K09664
[Presentation] Mode of Enhancement in the Global Hemostatic Potentials with Concomitant Use of Bypassing Agents and Emicizumab in Hemophilia A Patients with Inhibitor Evaluated by ROTEM2017
- Author(s)
  Yada K, Nogami K, Kitazawa T, Hattori K, Shima M
- Organizer
  the ISTH 2017 Congress
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-17H04231
[Presentation] Tenase (Xase) 反応軸に基づく中等症・軽症血友病Ａにおける異常FVIIIの多元的機能解析2017
- Author(s)
  矢田弘史, 野上恵嗣, 竹中亜利沙, 河村武志, 嶋緑倫
- Organizer
  第39回日本血栓止血学会学術集会
- Data Source
  KAKENHI-PROJECT-15K09664
[Presentation] Increasing of ternary complex formation by predominant accumulation of factor (F)X accompanied by increase of FIXa contributes to enhancement of clotting function by APCC in combination with emicizumab.2017
- Author(s)
  Yada K, Nogami K, Matsumoto T, Kitazawa T, Shima M
- Organizer
  59th ASH Annual meeting and Exposition
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-15K09664
[Presentation] A New Classification of Mild/Moderate Hemophilia Α Based on a Multi-Dimensional FVIII(a) Functions Evaluated By a Plasma-Based Factor Xa Generation2016
- Author(s)
  Yada K, Nogami K, Takenaka A, Kawamura T and Shima M
- Organizer
  58th ASH Annual meeting and Exposition
- Place of Presentation
  Sandiego, CA, USA
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-15K09664
[Presentation] 血友病の病態解析の進歩2016
- Author(s)
  矢田　弘史
- Organizer
  第38回日本血栓止血学会学術集会会長シンポジウム
- Place of Presentation
  奈良春日野国際フォーラム
- Data Source
  KAKENHI-PROJECT-15K09664
[Presentation] A Novel Plasma-based Factor Xa Generation Assay Defines Interaction Between FVIIIa and Each Component of Xase Complex in Mild Hemophilia A.2015
- Author(s)
  Kamiya N, Yada K, Nogami K, and Shima M
- Organizer
  The International Society on Thrombosis and Haemostasis (ISTH) 2015
- Place of Presentation
  Tronto, Canada
- Year and Date
  2015-06-23
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-15K09664
[Presentation] Arg593Cys変異を伴う軽症血友病Aにおける凝固障害はリン脂質との結合親和性低下に関連する2015
- Author(s)
  矢田弘史，野上恵嗣，神谷尚，嶋　緑倫
- Organizer
  第37回日本血栓止血学会学術集会
- Place of Presentation
  山梨県
- Year and Date
  2015-05-22
- Data Source
  KAKENHI-PROJECT-15K09664
[Presentation] Activated protein C-catalyzed factor Va inactivation is enhanced in the absence of factor VIIIa2014
- Author(s)
  矢田弘史，野上恵嗣，松本智子，北沢剛久，服部有宏，嶋　緑倫
- Organizer
  第76回日本血液学会学術集会
- Place of Presentation
  大阪国際会議場
- Year and Date
  2014-11-02
- Data Source
  KAKENHI-PROJECT-25860878
[Presentation] Activated protein C-catalyzed factor Va inactivation predominantly contributes to the downregulation of coagulation rather than factor VIIIa inactivation.2014
- Author(s)
  Yada K, Nogami K, Matsumoto T, Kitazawa T, Hattori K, Shima M
- Organizer
  56th ASH Annual meeting and Exposition
- Place of Presentation
  米国（サンフランシスコ）
- Year and Date
  2014-12-08
- Data Source
  KAKENHI-PROJECT-25860878
[Presentation] MC710はインヒビター存在下でも第VIII因子を直接活性化し,rFVIIaに比して相乗的に凝固機能を改善する2014
- Author(s)
  矢田弘史, 野上恵嗣, 嶋緑倫
- Organizer
  第36回日本血栓止血学会学術集会
- Place of Presentation
  大阪国際交流センター
- Year and Date
  2014-05-30
- Data Source
  KAKENHI-PROJECT-25860878
[Presentation] Reduced affinity to VWF/PL induced by a novel mutation at P1809L (factor VIII-Tenri) is the cause of mild hemophilia A developing anti-factor VIII inhibitor2013
- Author(s)
  Yada K, Nogami K , Takeyama M , Philip J. Fay and Shima M
- Organizer
  55th ASH Annual meeting and Exposition
- Place of Presentation
  New Orleans, U.S.A.
- Data Source
  KAKENHI-PROJECT-25860878
[Presentation] Different neutralizing effects of factor VIII concentrates associated with von willebrand factor and the inhibitor epitopes2013
- Author(s)
  Yada K , Nogami K, Ogiwara K and Midori Shima
- Organizer
  XXIV ISTH Congress of the International Society on Thrombosis and Haemostasis
- Place of Presentation
  Amsterdam,Netherlands
- Data Source
  KAKENHI-PROJECT-25860878
[Presentation] A novel mechanism of development of the inhibitor distinguishing self from non-self associated with Pro1809Leu mutation.2013
- Author(s)
  矢田弘史，野上恵嗣，武山雅博，嶋　緑倫
- Organizer
  第75回　日本血液学会学術集会
- Place of Presentation
  北海道札幌市
- Data Source
  KAKENHI-PROJECT-25860878
[Presentation] Management of Bypassing Therapy in Hemophilia Patients with Inhibitors Utilizing Global Coagulation Assay.2013
- Author(s)
  Yada K , Shima M
- Organizer
  2013 East Asia Hemophilia Forum
- Place of Presentation
  Seoul,Korea
- Data Source
  KAKENHI-PROJECT-25860878
[Presentation] Evaluation of the haemostatic potentials in a mild hemophilia A with a novel factor VIII mutation Thr677Ile2013
- Author(s)
  Yada K , Nogami K, Ogiwara K and Midori Shima
- Organizer
  XXIV ISTH Congress of the International Society on Thrombosis and Haemostasis
- Place of Presentation
  Amsterdam,Netherlands
- Data Source
  KAKENHI-PROJECT-25860878
[Presentation] Investigation of risk factors for hemophilic arthropathy in mild/moderate hemophilia A2013
- Author(s)
  矢田弘史, 野上恵嗣, 嶋緑倫
- Organizer
  第55回　日本小児血液がん学会学術集会
- Place of Presentation
  福岡県
- Data Source
  KAKENHI-PROJECT-25860878
[Presentation] 凝固一段法による第VIII因子活性(FVIII:C)が臨床的重症度を過小評価した軽症血友病Aの一例2013
- Author(s)
  矢田弘史，野上恵嗣, 荻原建一, 松本智子, 南博明, 古川晶子, 嶋緑倫
- Organizer
  第35回　日本血栓止血学会学術集会
- Place of Presentation
  山形県
- Data Source
  KAKENHI-PROJECT-25860878

1. 野上恵嗣 (50326328)

# of Collaborated Projects: 5 results

# of Collaborated Products: 31 results
2. Midori Shima (30162663)

# of Collaborated Projects: 1 results

# of Collaborated Products: 8 results
3. 武山雅博 (30572010)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
4. 松本智子 (80642678)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
5. 志田泰明

# of Collaborated Projects: 0 results

# of Collaborated Products: 1 results

Yada Koji 矢田 弘史

YADA Koji 矢田 弘史

Research Projects

Research Products

Co-Researchers

生体内病的環境下における血友病Aの病態解析と凝血学特性に基づく新規治療戦略の開発Principal Investigator

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

血友病A患者・保因者の第Ⅷ因子遺伝子型に基づく病態解析と新規個別化治療戦略の開発Principal Investigator

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

Development of novel therapeutic strategy based on hemostatic characteristics of FVIII in the patients with moderate/mild hemophilia APrincipal Investigator

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

Studies on molecular pathology of hemophilia A and gain-of-function of FVIII

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

Basic research on establishment of a novel hemostatic treatment based on the hemostatic potential for mild hemophilia A with inhibitorPrincipal Investigator

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

Basic reserch on hemostasis to establish a novel hemostatic therapy for hemophilia A patients with inhibitorsPrincipal Investigator

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

[Journal Article] Comparisons of global coagulation potential and bleeding episodes in emicizumab-treated hemophilia A patients and mild hemophilia A patients2022

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Emicizumab improves ex vivo clotting function in patients with mild/moderate hemophilia A2020

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Assessment of self‐/parent‐reported quality of life in Japanese children with haemophilia using the Japanese version of KIDSCREEN‐522020

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Novel Insights and New Developments Regarding Coagulation Revealed by Studies of the Anti-Factor IXa (Activated Factor IX)/Factor X Bispecific Antibody, Emicizumab.2020

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Global coagulation function assessed by rotational thromboelastometrypredicts coagulation-steady state in individual hemophilia A patients receiving emicizumab prophylaxis.2019

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Whole blood ristocetin-induced platelet impedance aggregometry does not reflect clinical severity in patients with type 1 von Willebrand disease. Haemophilia.2019

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Spotlight on emicizumab in the management of hemophilia A:patient selection and special considerations.2019

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Factor (F)VIII/VIIa enhances global haemostatic function in the co-presence of bypassing agents and FVIII among patients with haemophilia A with inhibitor2018

Author(s)

Journal Title

DOI

Yada Koji 矢田弘史

YADA Koji 矢田弘史